Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nasal provocation and immunotherapy.

A G Palma-Carlos1, M Branco-Ferreira, M C Santos

  • 1Clínica Universitária de Medicina I, Faculty of Medicine of Lisbon, Hospital de Santa Maria, Portugal.

Journal of Investigational Allergology & Clinical Immunology
|December 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial variability of soil organic carbon in native forest and agroforestry system in central Brazilian Amazonia.

Brazilian journal of biology = Revista brasleira de biologia·2025
Same author

Managing systemic reactions and venom immunotherapy in vespid-venom allergy: observations from a retrospective study of Portuguese patients.

European annals of allergy and clinical immunology·2024
Same author

Molecular sensitization profile to grass and olive pollens in Portugal.

European annals of allergy and clinical immunology·2024
Same author

Dupilumab in patients with atopic dermatitis - assessing treatment response, clinical features and potential biomarkers in real-life.

European annals of allergy and clinical immunology·2024
Same author

Efficacy of levamisole, ivermectin and moxidectin against Capillaria spp. in European hedgehogs (Erinaceus europaeus) - CORRIGENDUM.

Journal of helminthology·2024
Same author

Efficacy of levamisole, ivermectin and moxidectin against <i>Capillaria</i> spp. in European hedgehogs (<i>Erinaceus europaeus</i>).

Journal of helminthology·2023
Same journal

Safety, Adherence, and Effectiveness of an Increased Dose of Pollinex Quattro Grass and/or Olive in Real-World Practice.

Journal of investigational allergology & clinical immunology·2026
Same journal

Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Moderate-to-Severe Asthma, Type 2 Inflammation, and Nocturnal Awakenings: The MORPHEO Randomized Controlled Trial.

Journal of investigational allergology & clinical immunology·2026
Same journal

Severe Rituximab-Induced Cytokine Release Syndrome After Desensitization Successfully Treated With Tocilizumab: A Case Report.

Journal of investigational allergology & clinical immunology·2026
Same journal

Dysregulation of Mast Cell Prostaglandin in Food Anaphylaxis.

Journal of investigational allergology & clinical immunology·2026
Same journal

Extract-Negative Cofactor-Dependent Shrimp Anaphylaxis Caused by IgE Reactivity to Insoluble Muscle Proteins.

Journal of investigational allergology & clinical immunology·2026
Same journal

Antibiotic Allergy Labels in Hospitalized Patients: Results of a Multicenter Cross-Sectional Study.

Journal of investigational allergology & clinical immunology·2026
See all related articles

Specific immunotherapy (SIT) effectively manages allergic rhinitis by improving clinical scores and reducing drug needs. Nasal challenges provide objective evidence of SIT

Area of Science:

  • Immunology
  • Allergology
  • Otorhinolaryngology

Background:

  • Nasal mucosa is a primary site for allergic inflammation, with allergic rhinitis being a prevalent condition.
  • The nose serves as an accessible model for studying allergic responses and therapeutic interventions like specific immunotherapy (SIT).

Purpose of the Study:

  • To evaluate the clinical and immunological efficacy of specific immunotherapy (SIT) in patients with allergic rhinitis.
  • To investigate the utility of nasal challenges in assessing SIT's impact on allergic mediators.

Main Methods:

  • Patients with allergic rhinitis received injectable, nasal, or sublingual SIT.
  • Clinical outcomes (scores, nasal peak flow, drug use) were monitored during SIT.
  • Nasal provocation tests were performed, with measurements of tryptase and eosinophil cationic protein in nasal lavage fluid.

Related Experiment Videos

Main Results:

  • SIT demonstrated clinical efficacy, evidenced by improved clinical scores and reduced medication requirements.
  • Nasal provocation tests showed significant changes in mast cell and eosinophil mediator release post-SIT.
  • Objective immunological evidence of SIT's effect on key allergic cell populations was obtained.

Conclusions:

  • Specific immunotherapy is a valuable therapeutic strategy for allergic rhinitis.
  • Nasal challenges provide objective immunological data supporting the efficacy of SIT.
  • Further understanding of allergen desensitization mechanisms can be gained through these studies.